Comparison Between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients With Glucose Intolerance: NAGOYA HEART Study

No authors listed

No authors listed. Hypertension. 2018 Sep.

. 2018 Sep;72(3):e37-e38.

doi: 10.1161/HYP.0000000000000079.

No abstract available

Retraction of

Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.
Muramatsu T, Matsushita K, Yamashita K, Kondo T, Maeda K, Shintani S, Ichimiya S, Ohno M, Sone T, Ikeda N, Watarai M, Murohara T; NAGOYA HEART Study Investigators. Muramatsu T, et al. Hypertension. 2012 Mar;59(3):580-6. doi: 10.1161/HYPERTENSIONAHA.111.184226. Epub 2012 Jan 9. Hypertension. 2012. Retraction in: Hypertension. 2018 Sep;72(3):e37-e38. doi: 10.1161/HYP.0000000000000079. PMID: 22232134 Retracted. Clinical Trial.